Get started
BIOGEN INC. 15/25BIOGEN INC. 15/25BIOGEN INC. 15/25

BIOGEN INC. 15/25

No trades
See on Supercharts
Overview
Analysis News

IDPC chart


Full chart

Key terms


Outstanding amount
‪1.75 B‬ USD
Face value
1,000.00 USD
Minimum denomination
2,000.00 USD
Coupon
4.05% (Fixed)
Coupon frequency
Semi-annual
Yield to maturity
5.03%
Maturity date
Sep 15, 2025
Term to maturity
8 months

About BIOGEN INC. 15/25


Issuer
Biogen, Inc.
Sector
Health Technology
Home page
biogen.com
Issue date
Sep 15, 2015
Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS, SPINRAZA for the treatment of SMA, ADUHELM for the treatment of Alzheimer's disease, and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.

IDPC analysis


Advanced bond data for paid plans
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.

IDPC news